226 related articles for article (PubMed ID: 23868065)
21. Protein kinase C delta is required for survival of cells expressing activated p21RAS.
Xia S; Forman LW; Faller DV
J Biol Chem; 2007 May; 282(18):13199-210. PubMed ID: 17350960
[TBL] [Abstract][Full Text] [Related]
22. A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells.
Lee DH; Jung Jung Y; Koh D; Lim Y; Lee YH; Shin SY
Cancer Lett; 2016 Mar; 372(1):1-9. PubMed ID: 26742460
[TBL] [Abstract][Full Text] [Related]
23. The UPR reduces glucose metabolism via IRE1 signaling.
van der Harg JM; van Heest JC; Bangel FN; Patiwael S; van Weering JR; Scheper W
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):655-665. PubMed ID: 28093214
[TBL] [Abstract][Full Text] [Related]
24. Characterization of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
Yamada H; Omata-Yamada T; Lengyel P
J Biol Chem; 1991 Feb; 266(6):4002-9. PubMed ID: 1995648
[TBL] [Abstract][Full Text] [Related]
25. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
[TBL] [Abstract][Full Text] [Related]
26. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
[TBL] [Abstract][Full Text] [Related]
27. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
28. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
29. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
30. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.
Drosopoulos KG; Roberts ML; Cermak L; Sasazuki T; Shirasawa S; Andera L; Pintzas A
J Biol Chem; 2005 Jun; 280(24):22856-67. PubMed ID: 15757891
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
[TBL] [Abstract][Full Text] [Related]
32. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
33. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase.
Gardner AM; Johnson GL
J Biol Chem; 1996 Jun; 271(24):14560-6. PubMed ID: 8662985
[TBL] [Abstract][Full Text] [Related]
35. DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.
Lauth M; Bergström A; Shimokawa T; Tostar U; Jin Q; Fendrich V; Guerra C; Barbacid M; Toftgård R
Nat Struct Mol Biol; 2010 Jun; 17(6):718-25. PubMed ID: 20512148
[TBL] [Abstract][Full Text] [Related]
36. Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs.
Saqcena M; Mukhopadhyay S; Hosny C; Alhamed A; Chatterjee A; Foster DA
Oncogene; 2015 May; 34(20):2672-80. PubMed ID: 25023699
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation.
Masuelli L; Cutler ML
Mol Cell Biol; 1996 Oct; 16(10):5466-76. PubMed ID: 8816460
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.
Tikoo A; Cutler H; Lo SH; Chen LB; Maruta H
Cancer J Sci Am; 1999; 5(5):293-300. PubMed ID: 10526670
[TBL] [Abstract][Full Text] [Related]
39. Misfolded proteins bind and activate death receptor 5 to trigger apoptosis during unresolved endoplasmic reticulum stress.
Lam M; Marsters SA; Ashkenazi A; Walter P
Elife; 2020 Jan; 9():. PubMed ID: 31904339
[TBL] [Abstract][Full Text] [Related]
40. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism.
Wang HG; Millan JA; Cox AD; Der CJ; Rapp UR; Beck T; Zha H; Reed JC
J Cell Biol; 1995 May; 129(4):1103-14. PubMed ID: 7744959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]